{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:55:31Z","timestamp":1792810531555,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA046154"],"award-info":[{"award-number":["R21DA046154"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00213-021-05995-5","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T07:43:18Z","timestamp":1634283798000},"page":"1397-1408","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Cannabinoid tetrad effects of oral \u03949-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations"],"prefix":"10.1007","volume":"239","author":[{"given":"Catherine F.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise M.","family":"Weerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"issue":"7","key":"5995_CR1","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41386-019-0585-3","volume":"45","author":"AD Abraham","year":"2020","unstructured":"Abraham AD, Leung EJY, Wong BA, Rivera ZMG, Kruse LC, Clark JJ, Land BB (2020) Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain. Neuropsychopharmacology 45(7):1105\u20131114","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"5995_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.drugalcdep.2009.06.009","volume":"105","author":"L Booker","year":"2009","unstructured":"Booker L, Naidu PS, Razdan RK, Mahadevan A, Lichtman AH (2009) Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception. Drug Alcohol Depend 105(1\u20132):42\u201347","journal-title":"Drug Alcohol Depend"},{"key":"5995_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.drugalcdep.2017.01.046","volume":"175","author":"SC Britch","year":"2017","unstructured":"Britch SC, Wiley JL, Yu Z, Clowers BH, Craft RM (2017) Cannabidiol-Delta(9)-tetrahydrocannabinol interactions on acute pain and locomotor activity. Drug Alcohol Depend 175:187\u2013197","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"5995_CR4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/BF01940427","volume":"43","author":"S Burstein","year":"1987","unstructured":"Burstein S, Hunter SA, Latham V, Renzulli L (1987) A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice. Experientia 43(4):402\u2013403","journal-title":"Experientia"},{"issue":"1","key":"5995_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53(1):55\u201363","journal-title":"J Neurosci Methods"},{"issue":"1","key":"5995_CR6","first-page":"218","volume":"265","author":"DR Compton","year":"1993","unstructured":"Compton DR, Rice KC, De Costa BR, Razdan RK, Melvin LS, Johnson MR, Martin BR (1993) Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265(1):218\u2013226","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"5995_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/npp.2017.140","volume":"43","author":"ZD Cooper","year":"2018","unstructured":"Cooper ZD, Craft RM (2018) Sex-dependent effects of cannabis and cannabinoids: a translational perspective. Neuropsychopharmacology 43(1):34\u201351","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"5995_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1037\/pha0000257","volume":"27","author":"RM Craft","year":"2019","unstructured":"Craft RM, Britch SC, Buzitis NW, Clowers BH (2019) Age-related differences in Delta(9)-tetrahydrocannabinol-induced antinociception in female and male rats. Exp Clin Psychopharmacol 27(4):338\u2013347","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"5995_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0149-7634(05)80090-9","volume":"15","author":"WJ Dixon","year":"1991","unstructured":"Dixon WJ (1991) Staircase bioassay: the up-and-down method. Neurosci Biobehav Rev 15(1):47\u201350","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"5995_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ntt.2008.03.062","volume":"30","author":"D Dow-Edwards","year":"2008","unstructured":"Dow-Edwards D, Zhao N (2008) Oral THC produces minimal behavioral alterations in preadolescent rats. Neurotoxicol Teratol 30(5):385\u2013389","journal-title":"Neurotoxicol Teratol"},{"key":"5995_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.drugalcdep.2018.09.018","volume":"194","author":"CE Farquhar","year":"2019","unstructured":"Farquhar CE, Breivogel CS, Gamage TF, Gay EA, Thomas BF, Craft RM, Wiley JL (2019) Sex, THC, and hormones: effects on density and sensitivity of CB1 cannabinoid receptors in rats. Drug Alcohol Depend 194:20\u201327","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"5995_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/0091-3057(90)90354-K","volume":"35","author":"S Ferre","year":"1990","unstructured":"Ferre S, Guix T, Prat G, Jane F, Casas M (1990) Is experimental catalepsy properly measured? Pharmacol Biochem Behav 35(4):753\u2013757","journal-title":"Pharmacol Biochem Behav"},{"issue":"Suppl 1","key":"5995_CR13","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/j.pain.0000000000002268","volume":"162","author":"DP Finn","year":"2021","unstructured":"Finn DP, Haroutounian S, Hohmann AG, Krane E, Soliman N, Rice ASC (2021) Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies. Pain 162(Suppl 1):S5\u2013S25","journal-title":"Pain"},{"issue":"02","key":"5995_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4236\/pp.2015.62010","volume":"6","author":"R Gallily","year":"2015","unstructured":"Gallily R, Yekhtin Z, Hanu\u0161 LO (2015) Overcoming the bell-shaped dose-response of cannabidiol by using cannabis extract enriched in cannabidiol. Pharmacology & Pharmacy 6(02):75","journal-title":"Pharmacology & Pharmacy"},{"key":"5995_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pnpbp.2013.06.005","volume":"46","author":"FV Gomes","year":"2013","unstructured":"Gomes FV, Del Bel EA, Guimaraes FS (2013) Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice. Prog Neuropsychopharmacol Biol Psychiatry 46:43\u201347","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"5995_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","volume":"42","author":"F Grotenhermen","year":"2003","unstructured":"Grotenhermen F (2003) Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 42(4):327\u2013360","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"5995_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/BF02244012","volume":"100","author":"FS Guimaraes","year":"1990","unstructured":"Guimaraes FS, Chiaretti TM, Graeff FG, Zuardi AW (1990) Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology 100(4):558\u2013559","journal-title":"Psychopharmacology"},{"key":"5995_CR18","doi-asserted-by":"crossref","unstructured":"Henderson-Redmond AN, Sepulveda DE, Ferguson EL, Kline AM, Piscura MK, Morgan DJ (2021) Sex-specific mechanisms of tolerance for the cannabinoid agonists CP55,940 and delta-9-tetrahydrocannabinol (Delta(9)-THC). Psychopharmacology (Berl)","DOI":"10.1007\/s00213-021-05886-9"},{"issue":"12","key":"5995_CR19","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.euroneuro.2017.10.037","volume":"27","author":"T Hlozek","year":"2017","unstructured":"Hlozek T, Uttl L, Kaderabek L, Balikova M, Lhotkova E, Horsley RR, Novakova P, Sichova K, Stefkova K, Tyls F, Kuchar M, Palenicek T (2017) Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC. Eur Neuropsychopharmacol 27(12):1223\u20131237","journal-title":"Eur Neuropsychopharmacol"},{"issue":"9","key":"5995_CR20","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s00213-018-4946-0","volume":"235","author":"M Javadi-Paydar","year":"2018","unstructured":"Javadi-Paydar M, Nguyen JD, Kerr TM, Grant Y, Vandewater SA, Cole M, Taffe MA (2018) Effects of Delta9-THC and cannabidiol vapor inhalation in male and female rats. Psychopharmacology 235(9):2541\u20132557","journal-title":"Psychopharmacology"},{"key":"5995_CR21","doi-asserted-by":"publisher","first-page":"172741","DOI":"10.1016\/j.pbb.2019.172741","volume":"184","author":"M Javadi-Paydar","year":"2019","unstructured":"Javadi-Paydar M, Creehan KM, Kerr TM, Taffe MA (2019) Vapor inhalation of cannabidiol (CBD) in rats. Pharmacol Biochem Behav 184:172741","journal-title":"Pharmacol Biochem Behav"},{"key":"5995_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.brainres.2019.03.014","volume":"1715","author":"CHA Jesus","year":"2019","unstructured":"Jesus CHA, Redivo DDB, Gasparin AT, Sotomaior BB, de Carvalho MC, Genaro K, Zuardi AW, Hallak JEC, Crippa JA, Zanoveli JM, da Cunha JM (2019) Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors. Brain Res 1715:156\u2013164","journal-title":"Brain Res"},{"issue":"17","key":"5995_CR23","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1111\/bph.13887","volume":"174","author":"KM King","year":"2017","unstructured":"King KM, Myers AM, Soroka-Monzo AJ, Tuma RF, Tallarida RJ, Walker EA, Ward SJ (2017) Single and combined effects of Delta(9) -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain. Br J Pharmacol 174(17):2832\u20132841","journal-title":"Br J Pharmacol"},{"issue":"8","key":"5995_CR24","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s41386-019-0387-7","volume":"44","author":"LC Kruse","year":"2019","unstructured":"Kruse LC, Cao JK, Viray K, Stella N, Clark JJ (2019) Voluntary oral consumption of Delta(9)-tetrahydrocannabinol by adolescent rats impairs reward-predictive cue behaviors in adulthood. Neuropsychopharmacology 44(8):1406\u20131414","journal-title":"Neuropsychopharmacology"},{"key":"5995_CR25","doi-asserted-by":"crossref","unstructured":"Linher-Melville K, Zhu YF, Sidhu J, Parzei N, Shahid A, Seesankar G, Ma D, Wang Z, Zacal N, Sharma M, Parihar V, Zacharias R, Singh G (2020) Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Delta9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination. PLoS One 15(6), e0234176.","DOI":"10.1371\/journal.pone.0234176"},{"issue":"7","key":"5995_CR26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1017\/S1461145709990605","volume":"13","author":"LE Long","year":"2010","unstructured":"Long LE, Chesworth R, Huang XF, McGregor IS, Arnold JC, Karl T (2010) A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL\/6JArc mice. Int J Neuropsychopharmacol 13(7):861\u2013876","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"5995_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/can.2019.0037","volume":"4","author":"S Lunn","year":"2019","unstructured":"Lunn S, Diaz P, O\u2019Hearn S, Cahill SP, Blake A, Narine K, Dyck JRB (2019) Human pharmacokinetic parameters of orally administered Delta(9)-tetrahydrocannabinol capsules are altered by fed versus fasted conditions and sex differences. Cannabis Cannabinoid Res 4(4):255\u2013264","journal-title":"Cannabis Cannabinoid Res"},{"key":"5995_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pbb.2014.05.010","volume":"124","author":"R Marshell","year":"2014","unstructured":"Marshell R, Kearney-Ramos T, Brents LK, Hyatt WS, Tai S, Prather PL, Fantegrossi WE (2014) In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Delta9-THC in mice: inhalation versus intraperitoneal injection. Pharmacol Biochem Behav 124:40\u201347","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"5995_CR29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/0091-3057(91)90349-7","volume":"40","author":"BR Martin","year":"1991","unstructured":"Martin BR, Compton DR, Thomas BF, Prescott WR, Little PJ, Razdan RK, Johnson MR, Melvin LS, Mechoulam R, Ward SJ (1991) Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol Biochem Behav 40(3):471\u2013478","journal-title":"Pharmacol Biochem Behav"},{"key":"5995_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.drugalcdep.2014.01.019","volume":"137","author":"JA Marusich","year":"2014","unstructured":"Marusich JA, Lefever TW, Antonazzo KR, Craft RM, Wiley JL (2014) Evaluation of sex differences in cannabinoid dependence. Drug Alcohol Depend 137:20\u201328","journal-title":"Drug Alcohol Depend"},{"key":"5995_CR31","doi-asserted-by":"crossref","unstructured":"Metna-Laurent M, Mondesir M, Grel A, Vallee M, Piazza PV (2017) Cannabinoid-induced tetrad in mice. Curr Protoc Neurosci 80, 9 59 51\u201359 59 10","DOI":"10.1002\/cpns.31"},{"key":"5995_CR32","doi-asserted-by":"crossref","unstructured":"Mlost J, Bryk M, Starowicz K (2020) Cannabidiol for pain treatment: focus on pharmacology and mechanism of action. Int J Mol Sci 21(22)","DOI":"10.3390\/ijms21228870"},{"key":"5995_CR33","doi-asserted-by":"publisher","first-page":"173116","DOI":"10.1016\/j.pbb.2021.173116","volume":"202","author":"CF Moore","year":"2021","unstructured":"Moore CF, Davis CM, Harvey EL, Taffe MA, Weerts EM (2021) Appetitive, antinociceptive, and hypothermic effects of vaped and injected Delta-9-tetrahydrocannabinol (THC) in rats: exposure and dose-effect comparisons by strain and sex. Pharmacol Biochem Behav 202:173116","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"5995_CR34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/01.ftd.0000177223.19294.5c","volume":"27","author":"T Nadulski","year":"2005","unstructured":"Nadulski T, Pragst F, Weinberg G, Roser P, Schnelle M, Fronk EM, Stadelmann AM (2005) Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract. Ther Drug Monit 27(6):799\u2013810","journal-title":"Ther Drug Monit"},{"issue":"3","key":"5995_CR35","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1373\/clinchem.2016.265371","volume":"63","author":"MN Newmeyer","year":"2017","unstructured":"Newmeyer MN, Swortwood MJ, Andersson M, Abulseoud OA, Scheidweiler KB, Huestis MA (2017) Cannabis edibles: blood and oral fluid cannabinoid pharmacokinetics and evaluation of oral fluid screening devices for predicting delta(9)-tetrahydrocannabinol in blood and oral fluid following Cannabis Brownie Administration. Clin Chem 63(3):647\u2013662","journal-title":"Clin Chem"},{"key":"5995_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuropharm.2016.05.021","volume":"109","author":"JD Nguyen","year":"2016","unstructured":"Nguyen JD, Aarde SM, Vandewater SA, Grant Y, Stouffer DG, Parsons LH, Cole M, Taffe MA (2016) Inhaled delivery of Delta(9)-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology. Neuropharmacology 109:112\u2013120","journal-title":"Neuropharmacology"},{"key":"5995_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pbb.2018.07.007","volume":"172","author":"JD Nguyen","year":"2018","unstructured":"Nguyen JD, Grant Y, Kerr TM, Gutierrez A, Cole M, Taffe MA (2018) Tolerance to hypothermic and antinoceptive effects of 9-tetrahydrocannabinol (THC) vapor inhalation in rats. Pharmacol Biochem Behav 172:33\u201338","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"5995_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/BF02244975","volume":"107","author":"WR Prescott","year":"1992","unstructured":"Prescott WR, Gold LH, Martin BR (1992) Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat. Psychopharmacology 107(1):117\u2013124","journal-title":"Psychopharmacology"},{"issue":"7","key":"5995_CR39","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/npp.2013.31","volume":"38","author":"E Puighermanal","year":"2013","unstructured":"Puighermanal E, Busquets-Garcia A, Gomis-Gonzalez M, Marsicano G, Maldonado R, Ozaita A (2013) Dissociation of the pharmacological effects of THC by mTOR blockade. Neuropsychopharmacology 38(7):1334\u20131343","journal-title":"Neuropsychopharmacology"},{"issue":"18","key":"5995_CR40","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1007\/s00213-016-4378-7","volume":"233","author":"EM Rock","year":"2016","unstructured":"Rock EM, Connolly C, Limebeer CL, Parker LA (2016) Effect of combined oral doses of Delta(9)-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea in rat models. Psychopharmacology 233(18):3353\u20133360","journal-title":"Psychopharmacology"},{"key":"5995_CR41","doi-asserted-by":"crossref","unstructured":"Rohleder C, Pahlisch F, Graf R, Endepols H, Leweke FM (2020) Different pharmaceutical preparations of Delta(9) -tetrahydrocannabinol differentially affect its behavioral effects in rats. Addict Biol 25(3), e12745","DOI":"10.1111\/adb.12745"},{"issue":"5","key":"5995_CR42","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1037\/0735-7044.102.5.748","volume":"102","author":"PR Sanberg","year":"1988","unstructured":"Sanberg PR, Bunsey MD, Giordano M, Norman AB (1988) The catalepsy test: its ups and downs. Behav Neurosci 102(5):748\u2013759","journal-title":"Behav Neurosci"},{"issue":"3","key":"5995_CR43","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0014-2999(00)00044-3","volume":"391","author":"MC Sanudo-Pena","year":"2000","unstructured":"Sanudo-Pena MC, Romero J, Seale GE, Fernandez-Ruiz JJ, Walker JM (2000) Activational role of cannabinoids on movement. Eur J Pharmacol 391(3):269\u2013274","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"5995_CR44","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/BF00421466","volume":"40","author":"RD Sofia","year":"1975","unstructured":"Sofia RD, Vassar HB, Knobloch LC (1975) Comparative analgesic activity of various naturally occurring cannabinoids in mice and rats. Psychopharmacologia 40(4):285\u2013295","journal-title":"Psychopharmacologia"},{"key":"5995_CR45","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.copsyc.2019.04.002","volume":"30","author":"TR Spindle","year":"2019","unstructured":"Spindle TR, Bonn-Miller MO, Vandrey R (2019) Changing landscape of cannabis: novel products, formulations, and methods of administration. Curr Opin Psychol 30:98\u2013102","journal-title":"Curr Opin Psychol"},{"issue":"7","key":"5995_CR46","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1111\/bph.13024","volume":"172","author":"MA Taffe","year":"2015","unstructured":"Taffe MA, Creehan KM, Vandewater SA (2015) Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Delta(9) -tetrahydrocannabinol in Sprague-Dawley rats. Br J Pharmacol 172(7):1783\u20131791","journal-title":"Br J Pharmacol"},{"key":"5995_CR47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.phrs.2015.09.006","volume":"102","author":"S Tai","year":"2015","unstructured":"Tai S, Hyatt WS, Gu C, Franks LN, Vasiljevik T, Brents LK, Prather PL, Fantegrossi WE (2015) Repeated administration of phytocannabinoid Delta(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner. Pharmacol Res 102:22\u201332","journal-title":"Pharmacol Res"},{"issue":"1","key":"5995_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0014-2999(01)01267-5","volume":"430","author":"AH Tseng","year":"2001","unstructured":"Tseng AH, Craft RM (2001) Sex differences in antinociceptive and motoric effects of cannabinoids. Eur J Pharmacol 430(1):41\u201347","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"5995_CR49","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s00213-006-0356-9","volume":"186","author":"SA Varvel","year":"2006","unstructured":"Varvel SA, Wiley JL, Yang R, Bridgen DT, Long K, Lichtman AH, Martin BR (2006) Interactions between THC and cannabidiol in mouse models of cannabinoid activity. Psychopharmacology 186(2):226\u2013234","journal-title":"Psychopharmacology"},{"key":"5995_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drugalcdep.2014.07.029","volume":"143","author":"AA Wakley","year":"2014","unstructured":"Wakley AA, Wiley JL, Craft RM (2014) Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat. Drug Alcohol Depend 143:22\u201328","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"5995_CR51","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/clpt.1983.179","volume":"34","author":"ME Wall","year":"1983","unstructured":"Wall ME, Sadler BM, Brine D, Taylor H, Perez-Reyes M (1983) Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women. Clin Pharmacol Ther 34(3):352\u2013363","journal-title":"Clin Pharmacol Ther"},{"key":"5995_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neulet.2014.05.057","volume":"576","author":"JL Wiley","year":"2014","unstructured":"Wiley JL, Burston JJ (2014) Sex differences in Delta(9)-tetrahydrocannabinol metabolism and in vivo pharmacology following acute and repeated dosing in adolescent rats. Neurosci Lett 576:51\u201355","journal-title":"Neurosci Lett"},{"key":"5995_CR53","doi-asserted-by":"publisher","first-page":"110064","DOI":"10.1016\/j.pnpbp.2020.110064","volume":"106","author":"JL Wiley","year":"2021","unstructured":"Wiley JL, Barrus DG, Farquhar CE, Lefever TW, Gamage TF (2021) Sex, species and age: effects of rodent demographics on the pharmacology of (9)-tetrahydrocanabinol. Prog Neuropsychopharmacol Biol Psychiatry 106:110064","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"5995_CR54","doi-asserted-by":"crossref","unstructured":"Wiley JL, O'Connell MM, Tokarz ME, Wright MJ Jr (2007) Pharmacological effects of acute and repeated administration of Delta(9)-tetrahydrocannabinol in adolescent and adult rats. J Pharmacol Exp Ther 320(3), 1097-1105","DOI":"10.1124\/jpet.106.108126"},{"issue":"8","key":"5995_CR55","first-page":"3448","volume":"8","author":"A Zgair","year":"2016","unstructured":"Zgair A, Wong JC, Lee JB, Mistry J, Sivak O, Wasan KM, Hennig IM, Barrett DA, Constantinescu CS, Fischer PM, Gershkovich P (2016) Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines. Am J Transl Res 8(8):3448\u20133459","journal-title":"Am J Transl Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05995-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-021-05995-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05995-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T01:09:35Z","timestamp":1699664975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-021-05995-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["5995"],"URL":"https:\/\/doi.org\/10.1007\/s00213-021-05995-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.05.11.443601","asserted-by":"object"}]},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"10 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}